Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin).

Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin). Leukemia. 2002 Sep; 16(9):1627-36.

View in: PubMed

subject areas

Acute Disease
Adult
Aged
Aged, 80 and over
Aminoglycosides
Anti-Bacterial Agents
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Antigens, CD
Antigens, Differentiation, Myelomonocytic
Disease-Free Survival
Female
Humans
Immunotoxins
Leukemia, Myeloid
Male
Middle Aged
Monitoring, Physiologic
Neoplasm Recurrence, Local
Prognosis
Sialic Acid Binding Ig-like Lectin 3
Survival Rate

authors with profiles

Richard A. Larson